Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients, at the right moment, with the right data.

With the launch of Proscia Aperture^™, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies.

Clinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams.

And for everyone attending, the Partner Expo will feature breakthroughs in pathology AI, next-generation infrastructure, and enterprise solutions—delivered by the strongest ecosystem in the industry.